These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20377982)

  • 1. Balloon-assisted superselective intra-arterial cerebral infusion of bevacizumab for malignant brainstem glioma. A technical note.
    Riina HA; Knopman J; Greenfield JP; Fralin S; Gobin YP; Tsiouris AJ; Souweidane MM; Boockvar JA
    Interv Neuroradiol; 2010 Mar; 16(1):71-6. PubMed ID: 20377982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraarterial delivery of bevacizumab and cetuximab utilizing blood-brain barrier disruption in children with high-grade glioma and diffuse intrinsic pontine glioma: results of a phase I trial.
    McCrea HJ; Ivanidze J; O'Connor A; Hersh EH; Boockvar JA; Gobin YP; Knopman J; Greenfield JP
    J Neurosurg Pediatr; 2021 Oct; 28(4):371-379. PubMed ID: 34359048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superselective intraarterial cerebral infusion of bevacizumab: a revival of interventional neuro-oncology for malignant glioma.
    Riina HA; Fraser JF; Fralin S; Knopman J; Scheff RJ; Boockvar JA
    J Exp Ther Oncol; 2009; 8(2):145-50. PubMed ID: 20192120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term clinico-radiographic response to super-selective intra-arterial cerebral infusion of Bevacizumab for the treatment of vestibular schwannomas in Neurofibromatosis type 2.
    Riina HA; Burkhardt JK; Santillan A; Bassani L; Patsalides A; Boockvar JA
    Interv Neuroradiol; 2012 Jun; 18(2):127-32. PubMed ID: 22681725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article.
    Boockvar JA; Tsiouris AJ; Hofstetter CP; Kovanlikaya I; Fralin S; Kesavabhotla K; Seedial SM; Pannullo SC; Schwartz TH; Stieg P; Zimmerman RD; Knopman J; Scheff RJ; Christos P; Vallabhajosula S; Riina HA
    J Neurosurg; 2011 Mar; 114(3):624-32. PubMed ID: 20964595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bevacizumab and irinotecan treatment for progressive diffuse brainstem glioma: case report.
    Torcuator R; Zuniga R; Loutfi R; Mikkelsen T
    J Neurooncol; 2009 Jul; 93(3):409-12. PubMed ID: 19139822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Super-selective basilar artery infusion of bevacizumab and cetuximab for multiply recurrent pediatric ependymoma.
    Rajappa P; Krass J; Riina HA; Boockvar JA; Greenfield JP
    Interv Neuroradiol; 2011 Dec; 17(4):459-65. PubMed ID: 22192550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in endovascular neuro-oncology: endovascular selective intra-arterial (ESIA) infusion of targeted biologic therapy for brain tumors.
    Srinivasan VM; Lang FF; Chen SR; Chen MM; Gumin J; Johnson J; Burkhardt JK; Kan P
    J Neurointerv Surg; 2020 Feb; 12(2):197-203. PubMed ID: 31676690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endovascular superselective treatment of brain tumors: a new endovascular era? A quick review.
    Peschillo S; Miscusi M; Missori P
    J Neurointerv Surg; 2015 Mar; 7(3):222-4. PubMed ID: 24510377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study.
    Gururangan S; Chi SN; Young Poussaint T; Onar-Thomas A; Gilbertson RJ; Vajapeyam S; Friedman HS; Packer RJ; Rood BN; Boyett JM; Kun LE
    J Clin Oncol; 2010 Jun; 28(18):3069-75. PubMed ID: 20479404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superselective intra-arterial cerebral infusion of novel agents after blood-brain disruption for the treatment of recurrent glioblastoma multiforme: a technical case series.
    Shin BJ; Burkhardt JK; Riina HA; Boockvar JA
    Neurosurg Clin N Am; 2012 Apr; 23(2):323-9, ix-x. PubMed ID: 22440875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Superselective intra-arterial administration of bevacizumab with blood-brain barrier disruption in patients with recurrent malignant gliomas: case report and literature review].
    Kaprin AD; Zaitsev AM; Rerberg AG; Fedenko AA; Datsenko PV; Kirsanova ON
    Zh Vopr Neirokhir Im N N Burdenko; 2021; 85(5):64-70. PubMed ID: 34714005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study.
    Chakraborty S; Filippi CG; Wong T; Ray A; Fralin S; Tsiouris AJ; Praminick B; Demopoulos A; McCrea HJ; Bodhinayake I; Ortiz R; Langer DJ; Boockvar JA
    J Neurooncol; 2016 Jul; 128(3):405-15. PubMed ID: 26945581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective study of bevacizumab for treatment of brainstem glioma with malignant features.
    Moriya S; Ohba S; Adachi K; Nishiyama Y; Hayashi T; Nagahisa S; Kaito T; Nakae S; Hirose Y
    J Clin Neurosci; 2018 Jan; 47():228-233. PubMed ID: 29050897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superselective cerebral arterial infusion of BCNU in high-grade glioma: the radiologist's point of view.
    Fontaine S; Théron J; Melanson D; Villemure JG; Emrich J; Raymond J; Ethier R
    Can Assoc Radiol J; 1988 Sep; 39(3):178-81. PubMed ID: 2971050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of an intratumoral cyst on drug distribution by convection-enhanced delivery: case report.
    Ivasyk I; Morgenstern PF; Wembacher-Schroeder E; Souweidane MM
    J Neurosurg Pediatr; 2017 Sep; 20(3):256-260. PubMed ID: 28686124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.
    Norden AD; Young GS; Setayesh K; Muzikansky A; Klufas R; Ross GL; Ciampa AS; Ebbeling LG; Levy B; Drappatz J; Kesari S; Wen PY
    Neurology; 2008 Mar; 70(10):779-87. PubMed ID: 18316689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective intra-arterial chemotherapy with a combination of etoposide and cisplatin for malignant gliomas: preliminary report.
    Nakagawa H; Fujita T; Kubo S; Tsuruzono K; Yamada M; Tokiyoshi K; Miyawaki Y; Kanayama T; Kadota T; Hayakawa T
    Surg Neurol; 1994 Jan; 41(1):19-27. PubMed ID: 8310382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superselective intra-arterial cerebral infusion to improve brain tumor drug delivery.
    Rechberger JS; Hayes CA; Thiele F; Power EA; Daniels DJ
    Ther Deliv; 2022 Jan; 13(1):1-4. PubMed ID: 34726471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report.
    Pollack IF; Jakacki RI; Blaney SM; Hancock ML; Kieran MW; Phillips P; Kun LE; Friedman H; Packer R; Banerjee A; Geyer JR; Goldman S; Poussaint TY; Krasin MJ; Wang Y; Hayes M; Murgo A; Weiner S; Boyett JM
    Neuro Oncol; 2007 Apr; 9(2):145-60. PubMed ID: 17293590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.